• Neurones: Growth up 10.6% in 2021

    Source: Nasdaq GlobeNewswire / 09 Feb 2022 10:40:00   America/Chicago

    PRESS INFORMATION
    Heading: 2021 annual revenues        Nanterre, 9 February 2022 (after trading)

    Growth up 10.6% in 2021

    (unaudited, in € millions)20202021growth of which organic
    Revenues524.5579.9+ 10.6%+ 10.1%

    Achievements

    The latest forecasts for the year were exceeded, both in terms of activity and operating profit.

    The increase in revenues is as follows:

    • double-digit organic growth (+10.1%) which comes after a year of organic growth in 2020;
    • over the last three months of the year, revenues increased by 7.9%, in line with the previous quarter (+7.2%).

    In 2021, growth was driven by the Applications and Consulting business lines, and in particular by Digital and UX/UI. Regarding Infrastructure services, cybersecurity and migration to various cloud architectures are still buoyant.

    At €61.6 million*, operating profit rose sharply by 18.7%. At a rate of 10.6% of revenues, it is a record.

    Net cash and cash equivalents ** amounted to €264.6 million * at the end of the year.

    The full final annual results will be published on Wednesday, March 9, 2022 after the closing of the stock exchange.

    Outlook

    As usual, forecasts for the current year will be posted along with the Group's 1st quarter revenues.

    * being audited. ** excluding IFRS16 lease liabilities.

    About NEURONES

    With close to 6,000 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.

    Euronext Paris (compartment B - NRO) - Enternext Tech 40 – DSS mid caps
    www.neurones.net

    Press Relations:
    O'Connection
    Valérie Hackenheimer
    Tel.: +33 (0)6 12 80 35 20

    vhackenheimer@oconnection.fr


    NEURONES
    Matthieu Vautier
    Tel.: +33 (0)1 41 37 41 37
    rp@neurones.net
    Investor Relations:
    NEURONES
    Paul-César Bonnel
    Tel.: +33 (0)1 41 37 41 37
    investisseurs@neurones.net

    Attachment


Share on,